Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 17, 2007 | February 20, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 17, 2007 · Filed February 20, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 44,661 |
Ending reported balance
After 2007-02-20 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2007-02-17 · Tax withholding · Disposed 2,602 · Balance 46,095 Row 2 · 2007-02-18 · Tax withholding · Disposed 403 · Balance 45,692 Row 3 · 2007-02-20 · Tax withholding · Disposed 1,031 · Balance 44,661 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2007 Filed Feb 20, 2007 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,031 | $52.49 | $54,117.19 |
DisclosureSEC source: 0001104659-07-012361 · a4.xml · nonDerivative · entry 3 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,661 Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 403 | $52.49 | $21,153.47 |
DisclosureSEC source: 0001104659-07-012361 · a4.xml · nonDerivative · entry 2 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,692 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,602 | $52.49 | $136,578.98 |
DisclosureSEC source: 0001104659-07-012361 · a4.xml · nonDerivative · entry 1 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,095 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 403 | $44.15 | $17,792.45 |
DisclosureSEC source: 0001104659-06-011224 · a4.xml · nonDerivative · entry 1 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,197 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011224 · a4.xml · derivative · entry 3 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/2008 and 27,666 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011224 · a4.xml · nonDerivative · entry 2 Binder Jeffrey R · CIK 0001349819 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,697 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.